GRUPO DE ENVEJECIMIENTO CEREBRAL Y ENFERMEDADES NEURODEGENERATIVAS
GECYEN
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (33)
2022
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences, Vol. 23, Núm. 7
-
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2021
2020
-
Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164
-
Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum
Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42
2019
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910
2018
-
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice
Scientific Reports, Vol. 8, Núm. 1
2017
-
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors
Frontiers in Pharmacology, Vol. 8, Núm. OCT
-
Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation
Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784
2016
-
Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization
Frontiers in Pharmacology, Vol. 7, Núm. MAR
-
The potential of methylxanthine-based therapies in pediatric respiratory tract diseases
Respiratory Medicine, Vol. 112, pp. 1-9
-
Two affinity sites of the cannabinoid subtype 2 receptor identified by a novel homogeneous binding assay
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 3, pp. 580-587
2015
-
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738
-
Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
Biochemical Pharmacology, Vol. 96, Núm. 2, pp. 131-142
-
The relevance of theobromine for the beneficial effects of cocoa consumption
Frontiers in Pharmacology, Vol. 6, Núm. FEB
2014
-
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
Experimental Neurology, Vol. 261, pp. 44-52
-
Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine
PLoS ONE, Vol. 9, Núm. 3
-
G-Protein-Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System
CNS Neuroscience and Therapeutics, Vol. 20, Núm. 8, pp. 703-709
-
GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells
Hippocampus, Vol. 24, Núm. 7, pp. 733-739
-
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
British Journal of Pharmacology, Vol. 171, Núm. 23, pp. 5387-5406